Tag: zoonotic disease treatment market size

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Zoonotic Disease Treatment Market Forecast: Value Set To Climb From $45.48 Billion To $57.77 Billion

The zoonotic disease treatment market has experienced robust expansion over recent years. Its value is predicted to increase from $42.51 billion in 2025 to $45.48 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.0%. The expansion observed in the past can be linked to a rise in zoonotic disease transmission incidents, inadequate disease surveillance within animal populations, considerable reliance on conventional antibiotics, a deficiency in integrated animal and human health approaches, and greater interaction between humans and animals.

The zoonotic disease treatment market size is anticipated to expand significantly in the coming years. It is projected to increase to $57.77 billion in 2030, achieving a compound annual growth rate (CAGR) of 6.2%. This growth over the forecast period is attributed to advancements in zoonotic disease diagnostics and therapeutics, the growing adoption of One Health approaches, increased government funding for controlling zoonotic diseases, wider vaccination coverage for animals, and the expansion of global disease surveillance programs. Notable trends expected during this period include a rising occurrence of zoonotic disease outbreaks, an increasing focus on preventive treatment and prophylaxis, a growing demand for broad-spectrum anti-infective therapies, the broadening of integrated animal and human health initiatives, and an emphasis on early diagnosis and swift treatment initiation.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=15965&type=smp&name=Zoonotic%20Disease%20Treatment%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Zoonotic Disease Treatment Market Growth Backed By Core Demand Fundamentals

The zoonotic disease treatment market is anticipated to expand due to the rising demand for animal proteins. These proteins, sourced from animals like meat, dairy, eggs, and fish, provide all essential amino acids crucial for human well-being. This surge in demand for animal proteins can be attributed to an expanding global population, increased income levels, growing urbanization, and a greater understanding of the health benefits of animal-derived foods. Interventions for zoonotic diseases are vital as they provide strategies for handling illnesses linked to animal proteins, deciphering how they spread, developing effective remedies, and putting in place preventative actions to lessen risks to public health. For example, data from the Australian Bureau of Statistics (ABS) revealed that in March 2025, per capita consumption of meat and poultry products rose by 2.3% compared with 2023-24, indicating a notable increase in the country’s animal-based protein intake by weight. Consequently, the heightened demand for animal proteins is propelling the growth of the zoonotic disease treatment market. The expansion of the zoonotic disease treatment market is projected to be driven by increasing global livestock production. Livestock production encompasses the methodical, human-managed breeding, rearing, keeping, and utilization of domesticated animals to yield food, fiber, labor, and other goods for human use or consumption. The increase in global livestock production is largely a result of the growing demand for animal-based food products, fueled by population expansion and evolving dietary preferences. This production is crucial for zoonotic disease treatment as it provides an essential connection point for monitoring, researching, and managing animal health, facilitating the prompt identification of pathogens, the creation of vaccines and treatments, and the implementation of biosecurity measures that curb transmission between animals and humans, thereby strengthening integrated One Health initiatives. For instance, official statistics from UK government agencies indicated that in July 2025, the overall value of livestock output in the UK reached £20.1 ($23.69) billion in 2024, marking an increase of £1.1 ($1.30) billion or 5.6% compared to 2023. This growth was primarily attributed to higher prices and enhanced production across the eggs, beef, and milk sectors. Thus, the escalating global livestock production is a significant factor propelling the growth of the zoonotic disease treatment market.

Zoonotic Disease Treatment Market Segmentation: How Does The Market Break Down By Category?

The zoonotic disease treatment market covered in this report is segmented –

1) By Disease Type: Rabies, Tuberculosis, Leishmaniasis, Ebola Virus Disease, Other Disease Types

2) By Drug Class: Anti-Fungal, Anti-Bacterial, Antibiotics, Other Drug Classes

3) By Causative Agent: Bacteria, Virus, Nematode, Rodents, Ticks, Other Causative Agents

4) By Route Of Administration: Oral, Topical, Other Routes Of Administrations

5) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

Subsegments:

1) By Rabies: Post Exposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)

2) By Tuberculosis: Latent Tuberculosis Treatment, Active Tuberculosis Treatment

3) By Leishmaniasis: Visceral Leishmaniasis, Cutaneous Leishmaniasis, Mucocutaneous Leishmaniasis

4) By Ebola Virus Disease: Pre-Exposure Vaccination, Post-Exposure Treatment

5) By Other Disease Types: Zika Virus, Lassa Fever, Yellow Fever, Chikungunya

Zoonotic Disease Treatment Market Growth Trends Reshaping The Competitive Landscape

Leading companies within the zoonotic disease treatment market are concentrating their efforts on funding zoonotic disease treatment to improve diagnostic potential and refine treatment methods. This encompasses the creation of advanced diagnostic technologies, such as PCR kits, to allow for more rapid identification of zoonotic pathogens, alongside the implementation of specific therapeutic interventions. For example, in October 2023, BioPerfectus, a China-based biotechnology company specializing in diagnostic solutions, introduced thirteen new components to its Zoonotic Infectious Diseases Total PCR Solution. This expansion is designed to enhance its diagnostic capabilities for zoonotic diseases, which represent over 60% of identified infectious diseases and 75% of emerging infections. The undertaking is geared towards bolstering health security preparedness and response, particularly as climate change contributes to the spread of infectious diseases into previously unaffected areas. With these new offerings, the company aims to enable faster diagnoses and more effective management of zoonotic infections, emphasizing the critical role of proactive public health strategies.

Zoonotic Disease Treatment Market Top Companies Driving Competitive Growth

Major companies operating in the zoonotic disease treatment market are Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis International AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Zoetis Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, IDEXX Laboretories Inc., Hikma Pharmaceuticals PLC., Ceva Santé Animale, Vir Biotechnology Inc., Virbac, Vetoquinol S.A., BioCryst Pharmaceuticals Inc, Heska Corporation

View The Full Zoonotic Disease Treatment Market Report:

https://thebusinessresearchcompany.com/report/zoonotic-disease-treatment-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Zoonotic Disease Treatment Market Global Footprint: Which Region Leads The Market?

North America was the largest region in the zoonotic disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the zoonotic disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Forecasted Rise In Market Size Of The Zoonotic Disease Treatment Market During The Forecast Period?

The zoonotic disease treatment market has shown significant expansion in recent years. It is projected to increase from $42.51 billion in 2025 to $45.48 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.0%. This historical growth can be linked to frequent zoonotic disease transmission events, limited disease surveillance in animal populations, a high reliance on conventional antibiotics, an absence of coordinated animal and human health strategies, and increased human-animal interaction.

The zoonotic disease treatment market size is projected to experience substantial expansion in the coming years. This market is anticipated to reach $57.77 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.2%. Key drivers for this growth during the forecast period include advancements in zoonotic disease diagnostics and therapies, a greater embrace of “One Health” strategies, increased governmental investment in controlling zoonotic diseases, broader animal vaccination programs, and the growth of worldwide disease surveillance initiatives. Significant trends expected over the forecast period encompass a rising frequency of zoonotic disease outbreaks, a heightened emphasis on preventative care and prophylaxis, an increasing need for wide-ranging anti-infective treatments, the broadening of integrated animal and human health initiatives, and a focus on prompt diagnosis and swift treatment commencement.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15965&type=smp

Which Drivers Are Advancing The Zoonotic Disease Treatment Market Growth?

The increased demand for animal proteins is expected to propel the growth of the zoonotic disease treatment market going forward. Animal proteins are proteins derived from animal sources, such as meat, dairy, eggs, and fish, and contain all essential amino acids necessary for human health. The increased demand for animal proteins is due to the rising global population, higher income levels, urbanization, and growing awareness of the nutritional benefits of animal-based foods. Zoonotic disease treatments offer insights for managing diseases stemming from animal proteins, understanding transmission routes, developing effective therapies, and implementing preventive measures to mitigate public health risks. For instance, in March 2025, according to the Australian Bureau of Statistics (ABS) is an Australia-based official national statistical agency, meat and poultry products per capita increased by 2.3% compared with 2023-24. This reflects a clear rise in animal-based protein intake by weight in the national diet. Therefore, the increased demand for animal proteins is driving the growth of the zoonotic disease treatment market.

Zoonotic Disease Treatment Market Driver: Surge In Global Livestock Production Driving The Growth Of The Market Due To Rising Demand For Animal-Based Food Products

Growing global livestock production is expected to propel the growth of the zoonotic disease treatment market going forward. Livestock production refers to the systematic, human-managed breeding, raising, keeping, and utilization of domesticated animals (livestock) to generate food, fiber, labor, and other products for human consumption or use. Growing global livestock production is increasing due to the rising demand for animal-based food products driven by population growth and changing dietary preferences. Livestock production supports zoonotic disease treatment by serving as a critical interface for surveillance, research, and management of animal health, enabling early detection of pathogens, development of vaccines and therapeutics, and implementation of biosecurity practices that reduce transmission between animals and humans while strengthening integrated One Health responses. For instance, in July 2025, according to the official statistics, a UK-based government agencies, in 2024, the total value of livestock output in the UK was £20.1 ($23.69) billion, up £1.1 ($1.30) billion (+5.6%) compared with 2023. This growth was largely driven by higher prices and increased production in eggs, beef, and milk sectors. Therefore, growing global livestock production is driving the growth of the zoonotic disease treatment market.

How Is The Zoonotic Disease Treatment Market Distributed Across Key Segments?

The zoonotic disease treatment market covered in this report is segmented –

1) By Disease Type: Rabies, Tuberculosis, Leishmaniasis, Ebola Virus Disease, Other Disease Types

2) By Drug Class: Anti-Fungal, Anti-Bacterial, Antibiotics, Other Drug Classes

3) By Causative Agent: Bacteria, Virus, Nematode, Rodents, Ticks, Other Causative Agents

4) By Route Of Administration: Oral, Topical, Other Routes Of Administrations

5) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

Subsegments:

1) By Rabies: Post Exposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)

2) By Tuberculosis: Latent Tuberculosis Treatment, Active Tuberculosis Treatment

3) By Leishmaniasis: Visceral Leishmaniasis, Cutaneous Leishmaniasis, Mucocutaneous Leishmaniasis

4) By Ebola Virus Disease: Pre-Exposure Vaccination, Post-Exposure Treatment

5) By Other Disease Types: Zika Virus, Lassa Fever, Yellow Fever, Chikungunya

What Trends Are Influencing The Zoonotic Disease Treatment Market?

Major companies operating in the zoonotic disease treatment market are focused on investing in zoonotic disease treatment to enhance diagnostic capabilities and improving treatment protocols. This includes developing advanced diagnostic technologies, such as PCR kits, to facilitate quicker identification of zoonotic pathogens and implementing targeted therapeutic interventions. For instance, in October 2023, BioPerfectus, a China-based biotechnology company specializing in diagnostic solutions, launched the addition of thirteen new members to its Zoonotic Infectious Diseases Total PCR Solution. This enhancement aims to bolster its diagnostic capabilities for zoonotic diseases, which account for over 60% of known infectious diseases and 75% of emerging infections. The initiative is designed to improve health security preparedness and response, particularly as climate change facilitates the spread of infectious diseases to new regions. With these new products, the company aims to enable quicker diagnoses and better management of zoonotic infections, highlighting the importance of proactive public health measures.

Which Key Players Are Active In The Zoonotic Disease Treatment Market?

North America was the largest region in the zoonotic disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the zoonotic disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access The Complete Zoonotic Disease Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/zoonotic-disease-treatment-global-market-report

Which Region Accounts For The Highest Share Of The Zoonotic Disease Treatment Market?

North America was the largest region in the zoonotic disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the zoonotic disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Zoonotic Disease Treatment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=15965&type=smp

Get in touch with us:

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Biologics Market During 2026–2030?

The zoonotic disease treatment market has experienced robust expansion in recent years. Its valuation is projected to rise from $42.51 billion in 2025 to $45.48 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.0%. The historical growth can be attributed to frequent zoonotic disease transmission events, limited disease surveillance in animal populations, high dependence on conventional antibiotics, lack of coordinated animal and human health strategies, and increased human-animal interaction.

The zoonotic disease treatment market size is projected to experience significant expansion over the coming years. It is anticipated to grow to $57.77 billion in 2030, achieving a compound annual growth rate (CAGR) of 6.2%. This expected growth during the forecast period can be ascribed to progress in zoonotic disease diagnostics and therapies, increasing acceptance of One Health approaches, greater government financial support for zoonotic disease management, expanding vaccination coverage for animals, and the broadening of global disease surveillance programs. Key trends identified for this period include a rising occurrence of zoonotic disease outbreaks, an intensified focus on preventive treatment and prophylaxis, a growing requirement for broad-spectrum anti-infective treatments, the expansion of integrated animal and human health initiatives, and an emphasis on timely diagnosis and prompt treatment commencement.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15965&type=smp

Which Major Factors Are Driving The Expansion Of The Biologics Market?

A growing requirement for animal proteins is projected to drive the expansion of the zoonotic disease treatment market in the future. These proteins originate from animal sources like meat, dairy products, eggs, and fish, providing all vital amino acids essential for human well-being. This heightened demand for animal proteins stems from factors such as an expanding global population, greater disposable incomes, increasing urbanization, and a heightened understanding of the dietary advantages offered by animal-derived foods. Treatments for zoonotic diseases provide valuable understanding for addressing illnesses linked to animal proteins, deciphering how they spread, creating potent treatments, and putting in place preventative strategies to lessen dangers to public health. As an illustration, data from March 2025, reported by the Australian Bureau of Statistics (ABS) is an Australia-based official national statistical agency, showed a 2.3% increase in per capita consumption of meat and poultry products relative to 2023-24. This clearly indicates a significant rise in the national dietary intake of animal-based protein by weight. Consequently, the escalating demand for animal proteins is propelling the expansion of the zoonotic disease treatment market.

How Are The Various Segments Of The Biologics Market Categorized?

The zoonotic disease treatment market covered in this report is segmented –

1) By Disease Type: Rabies, Tuberculosis, Leishmaniasis, Ebola Virus Disease, Other Disease Types

2) By Drug Class: Anti-Fungal, Anti-Bacterial, Antibiotics, Other Drug Classes

3) By Causative Agent: Bacteria, Virus, Nematode, Rodents, Ticks, Other Causative Agents

4) By Route Of Administration: Oral, Topical, Other Routes Of Administrations

5) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

Subsegments:

1) By Rabies: Post Exposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)

2) By Tuberculosis: Latent Tuberculosis Treatment, Active Tuberculosis Treatment

3) By Leishmaniasis: Visceral Leishmaniasis, Cutaneous Leishmaniasis, Mucocutaneous Leishmaniasis

4) By Ebola Virus Disease: Pre-Exposure Vaccination, Post-Exposure Treatment

5) By Other Disease Types: Zika Virus, Lassa Fever, Yellow Fever, Chikungunya

What Trends Are Affecting The Expansion Of The Zoonotic Disease Treatment Market?

Leading companies operating in the zoonotic disease treatment market are channeling their investments into advancing diagnostic capabilities and enhancing treatment protocols. This involves developing sophisticated diagnostic technologies, such as PCR kits, to enable more rapid identification of zoonotic pathogens, along with implementing targeted therapeutic interventions. For instance, in October 2023, BioPerfectus, a China-based biotechnology company focused on diagnostic solutions, introduced thirteen new additions to its Zoonotic Infectious Diseases Total PCR Solution. This expansion aims to strengthen its diagnostic abilities for zoonotic diseases, which represent over 60% of known infectious diseases and 75% of emerging infections. The initiative is designed to improve preparedness and response for health security, especially as climate change aids the spread of infectious diseases to new regions. With these new offerings, the company intends to facilitate quicker diagnoses and better management of zoonotic infections, emphasizing the significance of proactive public health strategies.

Which Major Firms Influence Developments In The Biologics Market?

Major companies operating in the zoonotic disease treatment market are Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis International AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Zoetis Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, IDEXX Laboretories Inc., Hikma Pharmaceuticals PLC., Ceva Santé Animale, Vir Biotechnology Inc., Virbac, Vetoquinol S.A., BioCryst Pharmaceuticals Inc, Heska Corporation

Read the full zoonotic disease treatment market report here:

https://www.thebusinessresearchcompany.com/report/zoonotic-disease-treatment-global-market-report

Which Region Currently Holds The Largest Share Of The Biologics Market?

North America was the largest region in the zoonotic disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the zoonotic disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Biologics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15965&type=smp

Browse Through More Reports Similar to the Global Zoonotic Disease Treatment Market 2026, By The Business Research Company

Monkey Pox Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/monkey-pox-treatment-global-market-report

Animal Therapeutics And Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-therapeutics-and-diagnostics-global-market-report

Animal Medicine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-medicine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Biologics Market During 2026–2030?

The zoonotic disease treatment market has experienced robust expansion in recent years. Its valuation is projected to rise from $42.51 billion in 2025 to $45.48 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.0%. The historical growth can be attributed to frequent zoonotic disease transmission events, limited disease surveillance in animal populations, high dependence on conventional antibiotics, lack of coordinated animal and human health strategies, and increased human-animal interaction.

The zoonotic disease treatment market size is projected to experience significant expansion over the coming years. It is anticipated to grow to $57.77 billion in 2030, achieving a compound annual growth rate (CAGR) of 6.2%. This expected growth during the forecast period can be ascribed to progress in zoonotic disease diagnostics and therapies, increasing acceptance of One Health approaches, greater government financial support for zoonotic disease management, expanding vaccination coverage for animals, and the broadening of global disease surveillance programs. Key trends identified for this period include a rising occurrence of zoonotic disease outbreaks, an intensified focus on preventive treatment and prophylaxis, a growing requirement for broad-spectrum anti-infective treatments, the expansion of integrated animal and human health initiatives, and an emphasis on timely diagnosis and prompt treatment commencement.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15965&type=smp

Which Major Factors Are Driving The Expansion Of The Biologics Market?

A growing requirement for animal proteins is projected to drive the expansion of the zoonotic disease treatment market in the future. These proteins originate from animal sources like meat, dairy products, eggs, and fish, providing all vital amino acids essential for human well-being. This heightened demand for animal proteins stems from factors such as an expanding global population, greater disposable incomes, increasing urbanization, and a heightened understanding of the dietary advantages offered by animal-derived foods. Treatments for zoonotic diseases provide valuable understanding for addressing illnesses linked to animal proteins, deciphering how they spread, creating potent treatments, and putting in place preventative strategies to lessen dangers to public health. As an illustration, data from March 2025, reported by the Australian Bureau of Statistics (ABS) is an Australia-based official national statistical agency, showed a 2.3% increase in per capita consumption of meat and poultry products relative to 2023-24. This clearly indicates a significant rise in the national dietary intake of animal-based protein by weight. Consequently, the escalating demand for animal proteins is propelling the expansion of the zoonotic disease treatment market.

How Are The Various Segments Of The Biologics Market Categorized?

The zoonotic disease treatment market covered in this report is segmented –

1) By Disease Type: Rabies, Tuberculosis, Leishmaniasis, Ebola Virus Disease, Other Disease Types

2) By Drug Class: Anti-Fungal, Anti-Bacterial, Antibiotics, Other Drug Classes

3) By Causative Agent: Bacteria, Virus, Nematode, Rodents, Ticks, Other Causative Agents

4) By Route Of Administration: Oral, Topical, Other Routes Of Administrations

5) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

Subsegments:

1) By Rabies: Post Exposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)

2) By Tuberculosis: Latent Tuberculosis Treatment, Active Tuberculosis Treatment

3) By Leishmaniasis: Visceral Leishmaniasis, Cutaneous Leishmaniasis, Mucocutaneous Leishmaniasis

4) By Ebola Virus Disease: Pre-Exposure Vaccination, Post-Exposure Treatment

5) By Other Disease Types: Zika Virus, Lassa Fever, Yellow Fever, Chikungunya

What Trends Are Affecting The Expansion Of The Zoonotic Disease Treatment Market?

Leading companies operating in the zoonotic disease treatment market are channeling their investments into advancing diagnostic capabilities and enhancing treatment protocols. This involves developing sophisticated diagnostic technologies, such as PCR kits, to enable more rapid identification of zoonotic pathogens, along with implementing targeted therapeutic interventions. For instance, in October 2023, BioPerfectus, a China-based biotechnology company focused on diagnostic solutions, introduced thirteen new additions to its Zoonotic Infectious Diseases Total PCR Solution. This expansion aims to strengthen its diagnostic abilities for zoonotic diseases, which represent over 60% of known infectious diseases and 75% of emerging infections. The initiative is designed to improve preparedness and response for health security, especially as climate change aids the spread of infectious diseases to new regions. With these new offerings, the company intends to facilitate quicker diagnoses and better management of zoonotic infections, emphasizing the significance of proactive public health strategies.

Which Major Firms Influence Developments In The Biologics Market?

Major companies operating in the zoonotic disease treatment market are Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis International AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Zoetis Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, IDEXX Laboretories Inc., Hikma Pharmaceuticals PLC., Ceva Santé Animale, Vir Biotechnology Inc., Virbac, Vetoquinol S.A., BioCryst Pharmaceuticals Inc, Heska Corporation

Read the full zoonotic disease treatment market report here:

https://www.thebusinessresearchcompany.com/report/zoonotic-disease-treatment-global-market-report

Which Region Currently Holds The Largest Share Of The Biologics Market?

North America was the largest region in the zoonotic disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the zoonotic disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Biologics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15965&type=smp

Browse Through More Reports Similar to the Global Zoonotic Disease Treatment Market 2026, By The Business Research Company

Monkey Pox Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/monkey-pox-treatment-global-market-report

Animal Therapeutics And Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-therapeutics-and-diagnostics-global-market-report

Animal Medicine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-medicine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the manual tray sealers market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Zoonotic Disease Treatment Market reach by 2030 starting from 2026 levels?

The zoonotic disease treatment market size has experienced significant growth in recent years. It is projected to expand from $42.51 billion in 2025 to $45.48 billion in 2026, at a compound annual growth rate (CAGR) of 7.0%. This historical expansion can be attributed to frequent instances of zoonotic disease transmission, restricted disease surveillance in animal populations, a high dependency on conventional antibiotics, a deficiency in coordinated animal and human health strategies, and increased interaction between humans and animals.

The market for treating zoonotic diseases is anticipated to experience substantial expansion in the coming years. It is projected to reach $57.77 billion by 2030, showing a compound annual growth rate (CAGR) of 6.2%. This growth during the forecast period is attributable to progress in zoonotic disease diagnostics and therapeutics, increasing adoption of ‘One Health’ approaches, enhanced government funding for zoonotic disease control, expanding vaccination coverage in animals, and the broadening of global disease surveillance programs. Notable trends expected in the forecast period encompass a rising frequency of zoonotic disease outbreaks, a greater focus on preventive treatment and prophylaxis, increasing demand for broad-spectrum anti-infective therapies, the expansion of integrated animal and human health initiatives, and an emphasis on early diagnosis and rapid treatment commencement.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15965&type=smp

Which Drivers Are Influencing Long-Term Growth In The Zoonotic Disease Treatment Market?

A surge in the need for animal proteins is anticipated to fuel the expansion of the zoonotic disease treatment market in the foreseeable future. These proteins, obtained from animal sources like meat, dairy products, eggs, and fish, provide all vital amino acids crucial for human well-being. This heightened demand stems from an expanding worldwide population, increased disposable incomes, growing urbanization, and a greater understanding of the dietary advantages offered by foods derived from animals. Zoonotic disease treatments provide critical understanding for handling illnesses originating from animal proteins, identifying how they spread, creating potent treatments, and putting in place preventative strategies to lessen dangers to public health. As an illustration, the Australian Bureau of Statistics (ABS), Australia’s official national statistical agency, reported in March 2025 that the per capita consumption of meat and poultry products rose by 2.3% compared to 2023-24. This data indicates a noticeable increase in the intake of animal-based protein by weight within the national diet. Consequently, the escalating demand for animal proteins is a key factor propelling the growth of the zoonotic disease treatment market.

How Is The Zoonotic Disease Treatment Market Divided Into Segments?

The zoonotic disease treatment market covered in this report is segmented –

1) By Disease Type: Rabies, Tuberculosis, Leishmaniasis, Ebola Virus Disease, Other Disease Types

2) By Drug Class: Anti-Fungal, Anti-Bacterial, Antibiotics, Other Drug Classes

3) By Causative Agent: Bacteria, Virus, Nematode, Rodents, Ticks, Other Causative Agents

4) By Route Of Administration: Oral, Topical, Other Routes Of Administrations

5) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

Subsegments:

1) By Rabies: Post Exposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)

2) By Tuberculosis: Latent Tuberculosis Treatment, Active Tuberculosis Treatment

3) By Leishmaniasis: Visceral Leishmaniasis, Cutaneous Leishmaniasis, Mucocutaneous Leishmaniasis

4) By Ebola Virus Disease: Pre-Exposure Vaccination, Post-Exposure Treatment

5) By Other Disease Types: Zika Virus, Lassa Fever, Yellow Fever, Chikungunya

What Industry Trends Are Transforming The Zoonotic Disease Treatment Market?

Leading companies within the zoonotic disease treatment market are concentrating their investments on strengthening diagnostic capabilities and refining treatment protocols for zoonotic diseases. This strategy includes developing advanced diagnostic technologies, such as PCR kits, to allow for faster identification of zoonotic pathogens and implementing targeted therapeutic interventions. For instance, in October 2023, BioPerfectus, a China-based biotechnology company specializing in diagnostic solutions, announced the addition of thirteen new components to its Zoonotic Infectious Diseases Total PCR Solution. This enhancement aims to bolster its ability to diagnose zoonotic diseases, which comprise over 60% of all known infectious diseases and 75% of emerging infections. The initiative is intended to improve health security preparedness and response, especially as climate change contributes to the spread of infectious diseases into new geographic areas. With these new offerings, the company seeks to enable more rapid diagnoses and improved management of zoonotic infections, emphasizing the critical role of proactive public health measures.

Which Key Market Players Are Investing In Expansion And Innovation Within The Zoonotic Disease Treatment Market?

Major companies operating in the zoonotic disease treatment market are Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis International AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Zoetis Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, IDEXX Laboretories Inc., Hikma Pharmaceuticals PLC., Ceva Santé Animale, Vir Biotechnology Inc., Virbac, Vetoquinol S.A., BioCryst Pharmaceuticals Inc, Heska Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/zoonotic-disease-treatment-global-market-report

Which Regions Are Poised For Strategic Growth In The Zoonotic Disease Treatment Market?

North America was the largest region in the zoonotic disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the zoonotic disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Zoonotic Disease Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15965&type=smp

Browse Through More Reports Similar to the Global Zoonotic Disease Treatment Market 2026, By The Business Research Company

Monkey Pox Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/monkey-pox-treatment-global-market-report

Animal Therapeutics And Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-therapeutics-and-diagnostics-global-market-report

Animal Medicine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-medicine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the zoonotic disease treatment market from 2025–2034 with trusted insights from The Business Research Company

#How Big Is The Zoonotic Disease Treatment Market Size Today And What Will Its Value Be At The End Of 2029?#_x000D_

The valuation of the market dedicated to therapies for diseases transferable between animals and humans has experienced robust expansion recently, projected to climb from USD 39.71 billion in 2024 to USD 42.51 billion by 2025, reflecting a consistent annual growth rate of 7.0%. This upward trajectory observed throughout the past review period is primarily influenced by several factors: the advent of significant zoonotic disease incidents, the expanding concentration of populations in urban centers coupled with greater intrusion into natural habitats, the adoption of the ‘One Health’ paradigm, heightened monitoring and dissemination of findings, global interconnectedness, increased movement of people worldwide, and elevated public understanding and educational initiatives._x000D_

_x000D_

Anticipation surrounds the zoonotic disease treatment market, which is projected to experience robust expansion in the coming years, reaching a valuation of $54.84 billion by 2029, propelled by a compound annual growth rate (CAGR) of 6.6%; this projected upswing is fundamentally linked to shifts in climate and environmental conditions, increased financial backing from governmental and global bodies, innovations in medical science, supportive regulatory frameworks leading to smoother authorization processes, and cooperative efforts in research and development, while key patterns observed during this projection time frame encompass the creation of antivirals effective against a wide range of pathogens, vital enhancements to worldwide healthcare systems, progress in diagnostic tools, acceleration in vaccine creation methodologies, and a heightened emphasis on proactive health protection strategies._x000D_

_x000D_

#Access A Free Sample Of The Report:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=15965&type=smp_x000D_

_x000D_

#Which Key Drivers Are Powering Growth In The Zoonotic Disease Treatment Market?#_x000D_

The surging appetite for sustenance derived from animal sources is anticipated to be a primary catalyst for expansion within the market dedicated to addressing illnesses transmissible from animals to humans. Proteins sourced from animals, encompassing items like flesh, milk products, ovums, and aquatic life, are notable for furnishing the full spectrum of amino acids vital for sustaining human well-being. This heightened desire for animal proteins stems from several concurrent factors: a swelling global populace, elevated financial capacities, demographic shifts toward urban centers, and greater comprehension regarding the dietary advantages inherent in comestibles originating from animals. Interventions for zoonotic ailments furnish crucial knowledge for overseeing sicknesses originating in animal protein consumption, deciphering pathways of contagion, formulating successful remedies, and establishing safeguards to diminish widespread health perils. To illustrate this trend, a July 2023 publication from the Organisation for Economic Co-operation and Development and the Food and Agriculture Organization indicated that international consumption of meat is forecast to see an annual uptick of 0.1%, a projection centered on a US agricultural goods marketplace; this upswing is largely attributable to burgeoning requirements in nations with moderate to lower economic standing, wherein fowl is anticipated to constitute close to fifty percent of the collective augmentation in meat output by the year 2032, consequently establishing the growing need for animal proteins as a key propellant for the zoonotic disease treatment sector._x000D_

_x000D_

#Which Segment Categories Are Driving Maximum Growth In The Zoonotic Disease Treatment Market?#_x000D_

The zoonotic disease treatment market covered in this report is segmented – _x000D_

_x000D_

1) By Disease Type: Rabies, Tuberculosis, Malaria, Leishmaniasis, Ebola Virus Disease, Other Disease Types_x000D_

2) By Drug Class: Anti-Fungal, Anti-Bacterial, Antibiotics, Other Drug Classes_x000D_

3) By Causative Agent: Bacteria, Virus, Nematode, Rodents, Ticks, Other Causative Agents_x000D_

4) By Route Of Administration: Oral, Topical, Other Routes Of Administrations_x000D_

5) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels_x000D_

_x000D_

Subsegments:_x000D_

1) By Rabies: Post Exposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP) _x000D_

2) By Tuberculosis: Latent Tuberculosis Treatment, Active Tuberculosis Treatment _x000D_

3) By Malaria: Plasmodium falciparum Malaria, Plasmodium Vivax Malaria, Other Malaria Types _x000D_

4) By Leishmaniasis: Visceral Leishmaniasis, Cutaneous Leishmaniasis, Mucocutaneous Leishmaniasis _x000D_

5) By Ebola Virus Disease: Pre-Exposure Vaccination, Post-Exposure Treatment _x000D_

6) By Other Disease Types: Zika Virus, Lassa Fever, Yellow Fever, Chikungunya_x000D_

_x000D_

#What Key Trends Are Driving Growth In The Zoonotic Disease Treatment Market?#_x000D_

Leading enterprises within the sector dedicated to addressing zoonotic ailments are concentrating their resources on bolstering diagnostic proficiency and refining therapeutic methodologies. This strategic focus encompasses the creation of cutting-edge detection tools, exemplified by Polymerase Chain Reaction (PCR) kits designed for swift pathogen identification, alongside the deployment of meticulously planned therapeutic strategies. As a tangible example, in October of 2023, BioPerfectus, a firm rooted in China recognized for its diagnostic advancements, expanded its comprehensive PCR offerings for zoonotic infections by introducing thirteen novel components. Such an expansion is intended to significantly augment their capacity to diagnose these diseases, which are alarmingly responsible for more than sixty percent of identified infectious outbreaks and seventy-five percent of newly emerging ones. This particular effort is geared toward strengthening global health security readiness and the capacity to react effectively, especially given the role of environmental shifts in broadening the geographic reach of these infections, ultimately facilitating faster ailment identification and superior management of outbreaks through these proactive public health commitments._x000D_

_x000D_

#Who Are The Leading Companies Driving The Zoonotic Disease Treatment Market?#_x000D_

Major companies operating in the zoonotic disease treatment market are Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis International AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Zoetis Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, IDEXX Laboretories Inc., Hikma Pharmaceuticals PLC., Ceva Santé Animale, Vir Biotechnology Inc., Virbac, Vetoquinol S.A., BioCryst Pharmaceuticals Inc., Heska Corporation_x000D_

_x000D_

#Download The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/zoonotic-disease-treatment-global-market-report_x000D_

_x000D_

#Which Region Holds The Largest Share In The Zoonotic Disease Treatment Market Today?#_x000D_

North America was the largest region in the zoonotic disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the zoonotic disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_

_x000D_

#Get A Report Customized For You Here:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=15965&type=smp_x000D_

_x000D_

Browse Through More Reports Similar to the Global Zoonotic Disease Treatment Market 2025, By The Business Research Company_x000D_

_x000D_

Merkel Cell Carcinoma Treatment Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/merkel-cell-carcinoma-treatment-global-market-report_x000D_

_x000D_

Basal Cell Carcinoma Treatment Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/basal-cell-carcinoma-treatment-global-market-report_x000D_

_x000D_

Crohns Disease Cd Treatment Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/crohns-disease-cd-treatment-global-market-report_x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Zoonotic Disease Treatment Industry In 2025?

The zoonotic disease treatment market size has experienced significant growth in recent years. It is anticipated to increase from $39.71 billion in 2024 to $42.51 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.0%. This historical expansion can be attributed to the emergence of major zoonotic outbreaks, urbanization, and habitat encroachment, the implementation of a one health approach, enhanced surveillance and reporting, globalization, increased travel, and greater public awareness and education.

The zoonotic disease treatment market size is anticipated to undergo significant expansion in the next few years. It is projected to reach $54.84 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 6.6%. This growth during the forecast period is expected due to climate change and environmental factors, government and international funding, advancements in medical technology, regulatory support and streamlined approvals, and collaborative research and development. Key trends identified for this period include the development of broad-spectrum antivirals, a strengthening of global health infrastructure, advances in diagnostic technology, growth in vaccine development platforms, and an increased focus on preventive measures.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15965&type=smp

Which Drivers Are Shaping The Zoonotic Disease Treatment Industry’s Market Share?

The escalating need for animal proteins is projected to drive the expansion of the zoonotic disease treatment market. Animal proteins, sourced from items such as meat, dairy, eggs, and fish, supply all essential amino acids for human health. This amplified demand for animal proteins results from an expanding global population, increased income levels, growing urbanization, and a heightened awareness of the nutritional benefits offered by animal-based foods. Zoonotic disease treatments provide critical insights for addressing illnesses originating from animal proteins, understanding transmission pathways, formulating effective therapies, and implementing preventative measures to lessen public health hazards. For instance, in July 2023, a report published by the Organization for Economic Co-operation and Development and the Food and Agriculture Organization, a US-based agricultural commodity market, indicated that global meat consumption is expected to rise at an annual rate of 0.1%. This increment is primarily fueled by increasing demand in middle and lower-income countries, with poultry anticipated to constitute nearly half of the total growth in meat production by 2032. Consequently, the rising demand for animal proteins is propelling the growth of the zoonotic disease treatment market.

What Are The Key Segments In The Zoonotic Disease Treatment Market?

The zoonotic disease treatment market covered in this report is segmented –

1) By Disease Type: Rabies, Tuberculosis, Malaria, Leishmaniasis, Ebola Virus Disease, Other Disease Types

2) By Drug Class: Anti-Fungal, Anti-Bacterial, Antibiotics, Other Drug Classes

3) By Causative Agent: Bacteria, Virus, Nematode, Rodents, Ticks, Other Causative Agents

4) By Route Of Administration: Oral, Topical, Other Routes Of Administrations

5) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

Subsegments:

1) By Rabies: Post Exposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)

2) By Tuberculosis: Latent Tuberculosis Treatment, Active Tuberculosis Treatment

3) By Malaria: Plasmodium falciparum Malaria, Plasmodium Vivax Malaria, Other Malaria Types

4) By Leishmaniasis: Visceral Leishmaniasis, Cutaneous Leishmaniasis, Mucocutaneous Leishmaniasis

5) By Ebola Virus Disease: Pre-Exposure Vaccination, Post-Exposure Treatment

6) By Other Disease Types: Zika Virus, Lassa Fever, Yellow Fever, Chikungunya

What Are The Latest Industry Trends Transforming The Zoonotic Disease Treatment Market?

Leading companies operating in the zoonotic disease treatment market are prioritizing investments in zoonotic disease treatment to improve diagnostic capabilities and refine treatment protocols. This entails developing advanced diagnostic technologies, such as PCR kits, to enable more rapid identification of zoonotic pathogens, alongside implementing targeted therapeutic interventions. For instance, in October 2023, BioPerfectus, a China-based biotechnology company specializing in diagnostic solutions, introduced thirteen new additions to its Zoonotic Infectious Diseases Total PCR Solution. This enhancement is designed to strengthen its diagnostic capabilities for zoonotic diseases, which comprise over 60% of known infectious diseases and 75% of emerging infections. The initiative aims to bolster health security preparedness and response, especially as climate change accelerates the spread of infectious diseases to new regions. With these new products, the company seeks to facilitate quicker diagnoses and better management of zoonotic infections, underscoring the importance of proactive public health measures.

Which Leading Players Are Enhancing Their Zoonotic Disease Treatment Market Presence Worldwide?

Major companies operating in the zoonotic disease treatment market are Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis International AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Zoetis Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, IDEXX Laboretories Inc., Hikma Pharmaceuticals PLC., Ceva Santé Animale, Vir Biotechnology Inc., Virbac, Vetoquinol S.A., BioCryst Pharmaceuticals Inc., Heska Corporation

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/zoonotic-disease-treatment-global-market-report

Which Region Currently Holds The Largest Share Of The Zoonotic Disease Treatment Market?

North America was the largest region in the zoonotic disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the zoonotic disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Zoonotic Disease Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15965&type=smp

Browse Through More Reports Similar to the Global Zoonotic Disease Treatment Market 2025, By The Business Research Company

Merkel Cell Carcinoma Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/merkel-cell-carcinoma-treatment-global-market-report

Basal Cell Carcinoma Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/basal-cell-carcinoma-treatment-global-market-report

Crohns Disease Cd Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/crohns-disease-cd-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Zoonotic Disease Treatment Market Growth Evolved From 2024 To 2025, And What’s Ahead?

Over the past few years, the zoonotic disease treatment market has significantly expanded in size. From 2024 to 2025, it’s projected to increase from $39.71 billion to $42.51 billion, exhibiting a compound annual growth rate (CAGR) of 7.0%. The past growth has been stimulated by factors like the onset of significant zoonotic outbreaks, urbanization, habitat intrusion, the adoption of a one health approach, heightened surveillance and reporting, globalization, along with a boost in travel, and greater public knowledge and education.

The market for zoonotic disease treatment is predicted to exhibit robust expansion in the ensuing years. It is projected to swell to $54.84 billion by 2029, with a compound annual growth rate (CAGR) of 6.6%. Various factors like environmental and climate change, governmental and international financial support, progress in healthcare technology, regulation assistance and efficient approvals, along with cooperative research and development efforts, can be credited for this growth within the projected period. The forthcoming year’s significant trends encompass the creation of wide-ranging antivirals, fortification of global health systems, advancements in diagnostic technologies, burgeoning growth in the field of vaccine development and emphasis on preventative actions.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15965&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theZoonotic Disease Treatment Market?

The surge in demand for proteins derived from animals is predicted to accelerate the expansion of the market for treatment of zoonotic diseases. The sources of these animal proteins include meat, dairy products, eggs, and seafood, and they provide all the essential amino acids required for human wellness. A rise in the global population, increased income levels, urbanisation, and an enhanced understanding of the dietary advantages offered by animal products are responsible for this amplified demand for animal proteins. Treatments for zoonotic diseases provide strategies to manage illnesses associated with animal proteins, comprehend the methods of transmission, create effective therapies, and adopt measures to lessen risks to public health. For example, a July 2023 report by the Organization for Economic Co-operation and Development and the Food and Agriculture Organization mentioned a forecast for the global meat consumption in a US-based agricultural commodity market, indicating a yearly growth rate of 0.1%. This upswing is mainly due to the escalating demand in middle and lower-income countries, with predictions stating that poultry will contribute to almost half of the total growth in meat production by 2032. Consequently, this amplifying demand for animal proteins is propelling the expansion of the zoonotic disease treatment market.

Which Segments in the Zoonotic Disease Treatment Offer the Most Growth?

The zoonotic disease treatment market covered in this report is segmented –

1) By Disease Type: Rabies, Tuberculosis, Malaria, Leishmaniasis, Ebola Virus Disease, Other Disease Types

2) By Drug Class: Anti-Fungal, Anti-Bacterial, Antibiotics, Other Drug Classes

3) By Causative Agent: Bacteria, Virus, Nematode, Rodents, Ticks, Other Causative Agents

4) By Route Of Administration: Oral, Topical, Other Routes Of Administrations

5) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

Subsegments:

1) By Rabies: Post Exposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)

2) By Tuberculosis: Latent Tuberculosis Treatment, Active Tuberculosis Treatment

3) By Malaria: Plasmodium falciparum Malaria, Plasmodium Vivax Malaria, Other Malaria Types

4) By Leishmaniasis: Visceral Leishmaniasis, Cutaneous Leishmaniasis, Mucocutaneous Leishmaniasis

5) By Ebola Virus Disease: Pre-Exposure Vaccination, Post-Exposure Treatment

6) By Other Disease Types: Zika Virus, Lassa Fever, Yellow Fever, Chikungunya

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15965&type=smp

What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theZoonotic Disease Treatment Market?# Market?

North America was the largest region in the zoonotic disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the zoonotic disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Current Market Growth and Trends in the Zoonotic Disease Treatment Industry?

Top corporations in the zoonotic disease treatment market are incorporating zoonotic disease treatment investments to amplify diagnostic proficiency and upgrade treatment methodologies. Here, the production of advanced diagnostic tools, including PCR kits, is vital for faster detection of zoonotic pathogens and the application of specific therapeutic measures. Take for example, BioPerfectus, a Biotechnology firm based in China specializing in diagnostic solutions, who in October 2023 launched thirteen new members to enhance its Zoonotic Infectious Diseases Total PCR Solution. The introduced enhancement is aimed at boosting diagnostic competency for zoonotic diseases that contribute to more than 60% of identified infectious diseases and 75% of upcoming infections. This step is meant to enhance preparedness and response towards health security, primarily because climate change encourages the expansion of infectious diseases to new regions. By introducing these new products, the company focuses on quicker diagnosis and effective management of zoonotic diseases, stressing the need for proactive public health initiatives.

View the full report here:

https://www.thebusinessresearchcompany.com/report/zoonotic-disease-treatment-global-market-report

What Are the Key Elements That Define the Zoonotic Disease Treatment Market?

Zoonotic disease treatment refers to the medical interventions and therapies aimed at diagnosing, managing, and preventing illnesses caused by pathogens transmitted between animals and humans. This treatment involves a combination of medication, vaccination, hygiene practices, and control measures to reduce transmission and mitigate the impact of these infections on both animal and human populations.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15965

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theZoonotic Disease Treatment Market?

The increasing demand for animal proteins is expected to drive the growth of the zoonotic disease treatment market. Animal proteins, derived from sources like meat, dairy, and fish, are in greater demand due to the rising global population, higher incomes, urbanization, and the nutritional benefits of animal-based foods. Zoonotic disease treatments focus on managing diseases related to animal proteins by understanding transmission routes, developing therapies, and implementing preventive measures. For example, in July 2023, a report by the Organization for Economic Co-operation and Development and the Food and Agriculture Organization projected that global meat consumption would increase at an annual rate of 0.1%, with poultry accounting for half of the growth by 2032. This rising demand for animal proteins is contributing to the growth of the zoonotic disease treatment market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15965&type=smp

#What Long-Term Growth Rate is Expected for theZoonotic Disease Treatment Market Between 2025 and 2034?

The zoonotic disease treatment market size will grow from $39.71 billion in 2024 to $42.64 billion in 2025, at a CAGR of 7.4%. This growth is attributed to major zoonotic outbreaks, urbanization, habitat encroachment, the One Health approach, increased surveillance, reporting, globalization, and increased public awareness and education.

The zoonotic disease treatment market is projected to reach $55.92 billion in 2029, with a CAGR of 7.0%. Growth is attributed to climate change, government funding, medical technology advancements, regulatory support, and collaborative research. Trends include broad-spectrum antivirals, strengthening health infrastructure, diagnostic technology advances, vaccine development, and focus on prevention.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15965

What Are the Current Market Growth and Trends in theZoonotic Disease Treatment Market That Industry Players Should Watch?

Companies in the zoonotic disease treatment market are investing in diagnostic technologies and improving treatment protocols. For example, in October 2023, BioPerfectus, a China-based biotechnology company, added 13 new PCR kits to its Zoonotic Infectious Diseases Total PCR Solution. This enhancement aims to improve diagnostic capabilities for zoonotic diseases, which account for over 60% of known infectious diseases and 75% of emerging infections.

What Are the Major Market Players Making an Impact on theZoonotic Disease Treatment Market Growth?

Major companies operating in the zoonotic disease treatment market are Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis International AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Zoetis Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, IDEXX Laboretories Inc., Hikma Pharmaceuticals PLC., Ceva Santé Animale, Vir Biotechnology Inc., Virbac, Vetoquinol S.A., BioCryst Pharmaceuticals Inc., Heska Corporation

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/zoonotic-disease-treatment-global-market-report

How Are the Key Segments of the Zoonotic Disease Treatment Market Driving Opportunities and Innovations?

The zoonotic disease treatment market covered in this report is segmented –

1) By Disease Type: Rabies, Tuberculosis, Malaria, Leishmaniasis, Ebola Virus Disease, Other Disease Types

2) By Drug Class: Anti-Fungal, Anti-Bacterial, Antibiotics, Other Drug Classes

3) By Causative Agent: Bacteria, Virus, Nematode, Rodents, Ticks, Other Causative Agents

4) By Route Of Administration: Oral, Topical, Other Routes Of Administrations

5) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

Subsegments:

1) By Rabies: Post Exposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)

2) By Tuberculosis: Latent Tuberculosis Treatment, Active Tuberculosis Treatment

3) By Malaria: Plasmodium falciparum Malaria, Plasmodium Vivax Malaria, Other Malaria Types

4) By Leishmaniasis: Visceral Leishmaniasis, Cutaneous Leishmaniasis, Mucocutaneous Leishmaniasis

5) By Ebola Virus Disease: Pre-Exposure Vaccination, Post-Exposure Treatment

6) By Other Disease Types: Zika Virus, Lassa Fever, Yellow Fever, Chikungunya

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15965&type=smp

What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theZoonotic Disease Treatment Market?# Market Expansion?

North America was the largest region in the zoonotic disease treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the zoonotic disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Zoonotic Disease Treatment Market 2025, By The Business Research Company:

Merkel Cell Carcinoma Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/merkel-cell-carcinoma-treatment-global-market-report

Neuralgia Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/neuralgia-treatment-global-market-report

Crohn’s Disease (CD) Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/crohns-disease-cd-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 15% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the zoonotic disease treatment market grown in recent years?

The market for treating zoonotic diseases has seen significant growth in past years. The market value is projected to increase from $39.71 billion in 2024 to $42.64 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.4%. Factors contributing to this growth during the historic period include serious zoonotic outbreaks, urban development, invasion of natural habitats, the adoption of one health approach, enhanced surveillance and reporting protocols, globalisation, as well as improved travel abilities and public awareness and education.

How is the zoonotic disease treatment market size expected to evolve during the forecast period?

In the coming years, the market for zoonotic disease treatment is predicted to experience robust expansion. By 2029, it is forecasted to reach $55.92 billion, with a compound annual growth rate (CAGR) of 7.0%. This projected growth during the forecast period can be credited to several factors such as changing climate and environmental conditions, the presence of government and global funding, advances in medically-related technology, streamlined approval processes and regulatory backing, along with cooperative research and development efforts. Notable future trends include the creation of broad-spectrum antivirals, fortifying global health systems, advancements in diagnostic technology, expansion in the area of vaccine development, and an emphasis on preventive strategies.

Get your zoonotic disease treatment market report here!

https://www.thebusinessresearchcompany.com/report/zoonotic-disease-treatment-global-market-report

Which key drivers are propelling the zoonotic disease treatment market’s growth?

The growth of the zoonotic disease treatment market is set to escalate as the demand for animal proteins increases. Animal proteins, sourced from meats, dairy, eggs, and fish, comprise all the vital amino acids required for human health. This greater desire for animal proteins can be attributed to a burgeoning global population, escalating income levels, urbanization, and a heightened awareness regarding the nutritive advantages of animal-based foods. Treatments for zoonotic diseases are essential in managing diseases related to the consumption of animal proteins, understanding how they spread, developing impactful therapies, and putting in place preventative steps to lessen public health hazards. For instance, a report by the Organization for Economic Co-operation and Development and the Food and Agriculture Organization forecasted in July 2023 that the global meat consumption on a US-based agricultural commodity market would witness an annual increment of 0.1%. This surge can be largely attributed to increased demands from middle and lower-income countries. It’s predicted that poultry will constitute around half of the total growth in meat production by 2032. Therefore, the growing demand for animal proteins is fueling the zoonotic disease treatment market’s expansion.

What are the market segments in the zoonotic disease treatment industry?

The zoonotic disease treatment market covered in this report is segmented –

1) By Disease Type: Rabies, Tuberculosis, Malaria, Leishmaniasis, Ebola Virus Disease, Other Disease Types

2) By Drug Class: Anti-Fungal, Anti-Bacterial, Antibiotics, Other Drug Classes

3) By Causative Agent: Bacteria, Virus, Nematode, Rodents, Ticks, Other Causative Agents

4) By Route Of Administration: Oral, Topical, Other Routes Of Administrations

5) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

Subsegments:

1) By Rabies: Post Exposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)

2) By Tuberculosis: Latent Tuberculosis Treatment, Active Tuberculosis Treatment

3) By Malaria: Plasmodium falciparum Malaria, Plasmodium Vivax Malaria, Other Malaria Types

4) By Leishmaniasis: Visceral Leishmaniasis, Cutaneous Leishmaniasis, Mucocutaneous Leishmaniasis

5) By Ebola Virus Disease: Pre-Exposure Vaccination, Post-Exposure Treatment

6) By Other Disease Types: Zika Virus, Lassa Fever, Yellow Fever, Chikungunya

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15965&type=smp

Who are the key players steering the development of the zoonotic disease treatment market?

Major companies operating in the zoonotic disease treatment market are Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis International AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Zoetis Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, IDEXX Laboretories Inc., Hikma Pharmaceuticals PLC., Ceva Santé Animale, Vir Biotechnology Inc., Virbac, Vetoquinol S.A., BioCryst Pharmaceuticals Inc., Heska Corporation

What are the key trends shaping the future of the zoonotic disease treatment market?

Leading firms in the zoonotic disease treatment market are pushing the boundaries by putting their investment in the treatment of zoonotic diseases to enhance diagnostic abilities and refine treatment methodologies. They are striving to devise advanced diagnostic aids such as PCR kits which will speed up the process of detecting zoonotic pathogens and thus, streamline the corresponding treatment protocols. For instance, BioPerfectus, a biotech company based in China known for its diagnostic solutions launched thirteen new additions to its Zoonotic Infectious Diseases Total PCR Solution in October 2023. The intent is to boost its diagnostic performance for diagnosing zoonotic diseases, which are responsible for over 60% of recognized infections and 75% of emerging ones. This step is targeted towards fortifying health security readiness and responsiveness, particularly in light of the fact how climate change is contributing towards the extension of infectious diseases to untouched regions. The company aims to facilitate faster diagnosing and better handling of zoonotic infections with these new commodities, underscoring the significance of preemptive public health actions.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15965

Which regions are most influential in expanding the zoonotic disease treatment market?

North America was the largest region in the zoonotic disease treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the zoonotic disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Merkel Cell Carcinoma Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/merkel-cell-carcinoma-treatment-global-market-report

Neuralgia Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/neuralgia-treatment-global-market-report

Crohn’s Disease (CD) Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/crohns-disease-cd-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: